Pharmaceutical

STAT+: In setback, Pfizer abandons one weight loss pill...

Pfizer said that it had discontinued clinical trials of a once-daily weight loss...

Opinion: Health misinformation is rampant in youth base...

By the time a young player is meeting with an orthopedic surgeon, it is too late.

‘I felt like I was dying’: How women with postpartum de...

Five and a half months after Kristina Dulaney had her second daughter, she devel...

STAT+: STAT-Harris Poll: Nearly half of U.S. adults wou...

Almost half of U.S. adults would be willing to spend up to $100 a month for new ...

STAT+: As demand for Covid shots wanes, Moderna seeks i...

Questions about Modern's next act loom as demand for its Covid shots is waning a...

STAT+: ADA says all diabetes patients should be screene...

The American Diabetes Association said Sunday that all adults with type 2 diabet...

How abortion access changed in the first year after Roe...

How abortion access changed in the first year after Roe v. Wade, in 8 charts.

Does DIY still have a place in diabetes care? 

When Dana Lewis built her first artificial pancreas in 2014, she — and millions ...

STAT+: Two type 1 diabetes patients now freed from insu...

With two Type 1 diabetes patients now successfully treated, Vertex says it’s rea...

STAT+: Lilly’s obesity pill cuts 15% of weight at highe...

A pill under development by Lilly could offer weight loss benefits in parts of t...

In absence of Roe v. Wade, an abortion doctor dwells on...

“I actually want people to be less 'careful' when they talk about abortion and l...

Opinion: Peter Hotez is not alone: Online harassment of...

Attacks on experts threaten public safety by limiting access to scientific and m...

‘We fail people’: New data on disparities in Medicaid a...

Overall, the study found that 55% of Medicaid enrollees with opioid addiction re...

STAT+: Pharmalittle: FDA approves first gene therapy fo...

The states of California, New York, Illinois, Minnesota, Washington, and Wiscons...

STAT+: EU poised to reject Amylyx’s ALS drug, as the co...

European regulators are on the verge of rejecting an ALS drug from Amylyx Pharma...

STAT+: GSK settles first lawsuit set for a U.S. trial o...

GSK reached a settlement with a man who claimed its Zantac heartburn medication ...